Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/14520
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSaiyudthong S.
dc.contributor.authorMarsden C.A.
dc.date.accessioned2021-04-05T03:35:20Z-
dc.date.available2021-04-05T03:35:20Z-
dc.date.issued2011
dc.identifier.issn0951418X
dc.identifier.other2-s2.0-79957809174
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/14520-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-79957809174&doi=10.1002%2fptr.3325&partnerID=40&md5=4ca76b2ebc4fee092817500cb7eb7290
dc.description.abstractBergamot essential oil (BEO), Citrus aurantium subsp. bergamia (Risso) Wright & Arn. (Rutaceae), is used widely in aromatherapy to reduce stress and anxiety despite limited scientific evidence. A previous study showed that BEO significantly increased gamma-aminobutyric acid levels in rat hippocampus, suggesting potential anxiolytic properties. The aim of this study was to investigate the effect of BEO (1.0%, 2.5% and 5.0% w/w) administered to rats on both anxiety-related behaviours (the elevated plus-maze (EPM) and hole-board tests) and stress-induced levels of plasma corticosterone in comparison with the effects of diazepam. Inhalation of BEO (1% and 2.5%) and injection of diazepam (1 mg/kg, i.p.) significantly increased the percentage of open arm entries on the EPM. The percentage time spent in the open arms was also significantly enhanced following administration of either BEO (2.5% and 5%) or diazepam. Total arm entries were significantly increased with the highest dose (5%), suggesting an increase in locomotor activity. In the hole-board test, 2.5% BEO and diazepam significantly increased the number of head dips. 2.5% BEO and diazepam attenuated the corticosterone response to acute stress caused by exposure to the EPM. In conclusion, both BEO and diazepam exhibited anxiolytic-like behaviours and attenuated HPA axis activity by reducing the corticosterone response to stress. Copyright © 2010 John Wiley & Sons, Ltd.
dc.subject4 aminobutyric acid
dc.subject4 aminobutyric acid A receptor
dc.subjectbergamot oil
dc.subjectcorticosterone
dc.subjectdiazepam
dc.subjectacute stress
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanxiety
dc.subjectanxiety disorder
dc.subjectaromatherapy
dc.subjectarticle
dc.subjectcontrolled study
dc.subjectcorticosterone blood level
dc.subjectemotion
dc.subjectGABAergic system
dc.subjecthypothalamic paraventricular nucleus
dc.subjectlocomotion
dc.subjectmale
dc.subjectmaze test
dc.subjectneurotransmission
dc.subjectnonhuman
dc.subjectrat
dc.subjecttask performance
dc.subjecttranquilizing activity
dc.subjectAdministration, Inhalation
dc.subjectAnimals
dc.subjectAnti-Anxiety Agents
dc.subjectAnxiety Disorders
dc.subjectCorticosterone
dc.subjectDiazepam
dc.subjectMale
dc.subjectMaze Learning
dc.subjectOils, Volatile
dc.subjectPlant Extracts
dc.subjectPlant Oils
dc.subjectRats
dc.subjectRats, Wistar
dc.subjectCitrus aurantium
dc.subjectRattus
dc.subjectRutaceae
dc.titleAcute effects of bergamot oil on anxiety-related behaviour and corticosterone level in rats
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationPhytotherapy Research. Vol 25, No.6 (2011), p.858-862
dc.identifier.doi10.1002/ptr.3325
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.